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In Brief Liu et al. show that the Atg17-Atg31-Atg29 complex not only plays an essential role in autophagy induction but also regulates autophagosome-vacuole fusion. Specifically diminishing recruitment of the vacuolar SNARE Vam7 to the phagophore assembly site by the ternary complex and Atg11 results in defects in autophagosome-vacuole fusion.
INTRODUCTION
Macroautophagy (hereafter autophagy) is a highly controlled cellular degradative pathway where numerous cargoes including protein aggregates, superfluous or damaged organelles, and invading pathogens are targeted to the vacuole, or the analogous organelle in higher eukaryotes, the lysosome, for degradation [1] [2] [3] [4] . In yeast, during autophagy an initial double-membrane structure named the phagophore is formed at the phagophore assembly site (PAS). The phagophore engulfs its cargoes sequentially, while expanding through lipid addition. Following closure of the phagophore, the de novo formed autophagosome fuses with the vacuole. The cargoes together with the inner membrane of the autophagosome are degraded in the lumen before they are eventually recycled. Autophagy has many physiological roles, whereas autophagic dysfunction is associated with many pathologies, including cancer, diabetes, and certain types of neurodegenerative disease [5] [6] [7] .
Following the induction of autophagy, Atg17 is among the very first Atg proteins that translocate to the PAS [8, 9] . Atg17 forms a stable ternary complex with Atg31 and Atg29, with Atg31 positioned as the bridge between the other two proteins [10] . The Atg17-Atg31-Atg29 complex is indispensible for autophagy induction. First, this complex recruits other Atg proteins, including Atg1 and Atg13, to the PAS [11, 12] . Second, structural data indicate that this complex forms a dimer with two crescents [12, 13] ; this curved structure might enable the complex together with Atg1 and Atg13 to tether Atg9-containing vesicles, which may be membrane sources for autophagosome formation, positioning them for fusion into the expanding phagophore.
After formation of a complete autophagosome, the doublemembrane vesicle fuses with the vacuole. In yeast, previous studies have indicated that the fusion machinery for other targeting pathways that terminate at the vacuole is also required for autophagosome-vacuole fusion, including the Rab GTPase Ypt7, its guanine nucleotide exchange factor Mon1-Ccz1, and SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins [14] [15] [16] [17] [18] [19] [20] . Similarly, the homotypic fusion and protein sorting (HOPS) tethering complex, RAB7 and SNARE proteins also have a role in mammalian autophagy [21] [22] [23] [24] [25] [26] [27] . However, those studies in yeast were carried out in strains where the corresponding genes were deleted. As a result, all fusion events at the vacuole, not only autophagosome-vacuole fusion, were affected. Accordingly, those data have not provided specific information on the regulation of autophagosome-vacuole fusion.
Here, we found that the Atg17-Atg31-Atg29 complex coordinates with Atg11 to recruit the SNARE protein Vam7 to the PAS when autophagy is induced. Impaired recruitment of Vam7 resulted in a defect in autophagosome-vacuole fusion and diminished autophagy flux. The results demonstrate that distinct molecular machinery is employed for regulating autophagy-vacuole fusion. Moreover, these data reveal a role of the Atg17-Atg31-Atg29 complex at a late stage of autophagy.
RESULTS
The Atg17-Atg31-Atg29 Complex Interacts with the Vam7 SNARE Protein at the PAS The Atg17-Atg31-Atg29 complex is a scaffold that is vital for PAS organization during autophagy induction. In a genome-wide study of protein-protein interaction via the yeast two-hybrid (Y2H) assay, Atg17 was found to bind Vam7, a vacuolar SNARE protein [28] . This interaction appears counterintuitive because the Atg17-Atg31-Atg29 complex was thought to only act at a very early stage of autophagy, whereas Vam7 is required for autophagosome fusion with the vacuole, a relatively late stage of the process. Therefore, we wanted to determine whether this interaction was valid and might reveal a novel role of the Atg17-Atg31-Atg29 complex in regulating autophagy.
First, we confirmed the previous result, interaction between Atg17 and Vam7, using the Y2H assay with the wild-type Y2H strain PJ69-4A (data not shown). Although it is a useful system, in the Y2H assay proteins are typically overexpressed and artificially directed to the nucleus. Therefore, to further validate the Atg17-Vam7 interaction, we utilized another assay, bimolecular fluorescence complementation (BiFC) [29] . In this assay, the Venus yellow fluorescent protein (vYFP) is split into two fragments, VN (N terminus of vYFP), and VC (C terminus of vYFP), and these are separately tagged to two proteins of interest. If the two proteins are able to interact, VN and VC will be brought into proximity with each other and are essentially able to reform the native threedimensional structure of vYFP and emit a fluorescent signal.
We tested the interactions between VC-Vam7 and the respective Atg(17, 29, or 31)-VN fusion proteins. None of the three pairs produced a detectable signal under growing conditions (YPD medium, ''+N''). In contrast, a substantial percentage of Atg17-VN VC-Vam7 and Atg29-VN VC-Vam7, but not Atg31-VN VCVam7, cells displayed a vYFP signal under starvation conditions (SD-N medium, ''-N'') ( Figure 1A ). As controls, we examined Atg17-VN VC, Atg29-VN VC, and Atg31-VN VC cells, where only the VC peptide was expressed. None of the cells expressing these combinations showed a vYFP signal even under starvation conditions ( Figure S1A ). In addition, similar to Vam7, the Vam3 protein is a vacuolar SNARE that is needed for the fusion of autophagosomes with the vacuole. As an additional control for the specificity of the Atg17-Vam7 interaction, we examined whether any of the components of the Atg17-Atg31-Atg29 complex showed an interaction with Vam3 via the BiFC assay; however, in all cases the results were negative ( Figure S1B ; data not shown).
Next, we wanted to determine where the interaction between the ternary complex and Vam7 occurs. Under starvation conditions, approximately 60% of the Atg17-Vam7 puncta (i.e., a vYFP signal) colocalized with CFP-Atg8, a PAS marker ( Figure 1B ). These colocalized puncta were located next to the vacuole, suggesting that the Atg17-Atg31-Atg29 complex recruits Vam7 to the PAS in autophagy-inducing conditions.
The Atg17-Atg31-Atg29 Complex Recruits Cytosolic Vam7 to the PAS at an Early Stage of Autophagy The next question we addressed was to examine when the Atg17-Atg31-Atg29 complex recruits Vam7 to the PAS. In particular, we wanted to determine whether this recruitment occurs at an early stage of autophagy when the ternary complex itself translocates to the PAS or only after autophagosome completion, as is the case with the mammalian protein STX17 that is recruited to completed autophagosomes to allow fusion with the lysosome [26] . To answer this question, we deleted ATG1 or ATG9 in the ATG17-VN VC-VAM7 strain. In atg1D or atg9D cells, autophagy can be initiated, but complete autophagosomes cannot be formed. A vYFP signal was still observed in the null strains after nitrogen starvation, indicating that the Atg17-Atg31-Atg29 complex is able to recruit Vam7 to the PAS at an early stage of autophagy (Figure 2A) . Noticeably, the percentage of cells showing vYFP puncta was significantly higher in the atg1D and atg9D strains compared to the wild-type (WT) strain ( Figure 2B ). This higher level of Atg17-VN-VC-Vam7 puncta likely reflects the block in autophagy and the accumulation of autophagy-related proteins at the PAS. There are two pools of cellular Vam7; one of these pools is cytosolic, and the other is associated with the vacuolar membrane through its phox homology (PX) domain, which binds phosphatidylinositol-3-phosphate (PtdIns3P) [30] . We constructed a strain with VC-Vam7 DPX and Atg17-VN to determine whether membrane binding was required for the Atg17-Vam7 interaction. The truncated VC-Vam7 DPX protein was as stable as the WT protein ( Figure 2C ), but a previous study demonstrated that Vam7 DPX localizes only in the cytosol [30] . To verify the localization of the Vam7 construct lacking the PX domain, we compared the phenotype of Vam7-GFP to Vam7 DPX -GFP. In contrast to the punctate and vacuolar membrane distribution seen with Vam7-GFP, the Vam7 DPX -GFP chimera was distributed diffusely in the cytosol ( Figure S2A ). In addition, we examined the subcellular distribution of the proteins by fractionation. VC-Vam7 was located primarily in the vacuole membrane-enriched P13 fraction, in addition to a cytosolic pool, whereas VC-Vam7
DPX was recovered entirely in the cytosolic supernatant fraction ( Figure S2B ). Despite its strictly cytosolic localization, under starvation conditions, we were still able to observe a vYFP signal corresponding to Atg17-VN-VCVam7 DPX ( Figures 2D and 2E ). Moreover, these BiFC dots showed good colocalization with CFP-Atg8, implying that the Atg17-Atg31-Atg29 complex recruits cytosolic Vam7 to the PAS ( Figure 2D ). Nonetheless, we cannot rule out the possibility that this complex is also able to recruit membrane-associated Vam7 to the PAS. Even though the PX domain of Vam7 was not required for the interaction with Atg17, we wondered whether it was necessary for normal autophagy activity. Based on a well-established quantitative autophagy assay, the Pho8D60 assay [31] [32] [33] , cells expressing VC-Vam7 DPX showed almost a complete block in autophagy, while the activity of VC-Vam7 cells was comparable to wild-type cells ( Figure S2C ). This finding suggests that the PX domain of Vam7 plays some other indispensible role(s) in autophagy.
Atg17 Directly Interacts with the SNARE Domain of Vam7
In order to examine the functional consequences of disrupting the interaction between the Atg17-Atg31-Atg29 complex and Vam7, we first asked which component(s) in the ternary complex mediates the interaction. In the BiFC assay, both Atg17-VN-VCVam7 and Atg29-VN-VC-Vam7 cells showed a vYFP signal (Figure 1A ). To determine whether one or both of these interactions was direct, we deleted ATG31 in both strains because this protein is the primary connection for Atg17 with Atg29 in the complex. We found that the Atg17-VN-VC-Vam7 cells still produced BiFC dots in the absence of Atg31, and these dots colocalized with CFP-Atg8 under starvation conditions (Figures 3A and 3B). In contrast, an Atg29-VN-VC-Vam7 signal was no longer detected after deletion of ATG31 ( Figures 3C and 3D ).
We have previously constructed a multiple-knockout (MKO) Y2H strain, in which most of the known ATG genes are deleted, including ATG29 and ATG31 [10] . In this MKO Y2H strain, we found that cells with AD-Atg17 and BD-Vam7 still showed robust growth on selection plates, suggesting that the interaction between Atg17 and Vam7 was independent of most other Atg proteins ( Figure 3E ). As expected, Atg29 was not able to bind Vam7 in the MKO Y2H strain, in agreement with our results using the wild-type Y2H strain (data not shown).
Next, we decided to map the Vam7 domain that is required for binding Atg17. Vam7 consists of the N-terminal PX domain, an intermediate region and a C-terminal SNARE domain [30, 34] . We constructed a set of BD-Vam7 constructs that contain various domains of the Vam7 protein ( Figure 3F ). Only cells with AD-Atg17 and BD-Vam7 241-316 , which contains only the SNARE domain, showed stronger growth on selective plates than the control. In agreement with this result, BDVam7
, in which only the SNARE domain was deleted, was not able to interact with AD-Atg17 ( Figure 3F ). These results suggest that the SNARE domain of Vam7 is necessary and sufficient for interaction with Atg17.
To further validate our findings that Vam7 binds Atg17 and that the SNARE domain mediates this interaction, we carried out an in vitro affinity isolation analysis. Escherichia coli cells were transformed with plasmids expressing Atg17-hexahistidine (6xHis) and glutathione S-transferase (GST) alone or as a GST-Vam7 SNARE domain chimera (GST-SNARE). Cell lysates were loaded onto glutathione resin and after extensive washing the proteins were eluted and analyzed by western Affinity isolation experiments were performed by co-expressing His-tagged Atg17 with either the GST-tagged Vam7 SNARE domain or the GST tag alone as described in Experimental Procedures. The Coomassie-stained gel shows the GST construct inputs. Glutathione resin was used for precipitation, and the western blot was probed using anti-His antibody. TL, total lysate; E, eluate.
blot. GST-SNARE, but not GST alone, was able to affinity isolate Atg17-6xHis ( Figure 3G ). Based on these results, we conclude that Atg17 directly interacts with the SNARE domain of Vam7.
Hydrophobic Residues in Helix 1 and Helix 4 of Atg17 Mediate Its Interaction with Vam7
We could not block the interaction between Atg17 and Vam7 by deleting the SNARE domain without affecting all fusion events at the vacuole. Thus, in order to determine the function of the recruitment of Vam7 by Atg17, we needed to turn instead to Atg17. Deletion of ATG17 blocks autophagy at a very early stage, which would obscure a potential role for Atg17 in regulating autophagosome-vacuole fusion. Accordingly, we needed to identify an Atg17 mutant that specifically affects the Atg17-Vam7 interaction without disrupting its interaction with Atg31-Atg29 or Atg13-Atg1. The crystal structure of a partial Atg17-Atg31-Atg29 complex has been resolved, indicating the presence of four highly organized a helices in Atg17 [13] . To map the domains required for interaction with Vam7, a set of AD-Atg17 deletion mutants were constructed ( Figures 4A and S3A ). Atg17 deletion mutants that lack part of helix 1 (92-106) or helix 4 (296-312 or 313-334) showed diminished interaction with Vam7 by the Y2H assay ( Figures 4A and S3A) .
Because we had shown that the SNARE domain of Vam7, which is also in a helix structure, mediates its interaction with Atg17, we hypothesized that the binding between Atg17 and Vam7 is due to a ''helix-helix'' interaction, which is usually mediated by hydrophobic residues from both sides of the interacting helices. Based on an alignment of yeast Atg17 homologs, we chose the conserved hydrophobic residues from 92-106 and 296-334, namely, I98, L105, I310, L313, I314, F317, I325, and L331, for further analysis ( Figure S3B ).
We mutated these residues to charged hydrophilic residues by site directed mutagenesis and tested their interaction with Vam7 by the Y2H assay. Among the mutants that we tested, Atg17 L105D , Atg17 F317D , and Atg17 I325D showed diminished interaction with Vam7 ( Figure 4B) . As a control, we tested the stability of these mutants compared to the WT protein. The GFP-Atg17 L313K,I314D , GFP-Atg17 L105D , and GFP-Atg17 F317D mutants were somewhat less stable than the GFP-Atg17 WT protein ( Figure S3C ). However, because the AD-Atg17
mutant still showed a strong interaction with BD-Vam7 (Figure 4B) , the impaired interaction with Vam7 seen with the Atg17 L105D , Atg17 F317D , and Atg17 I325D mutants was unlikely to be due to a lower level of the mutant proteins.
To confirm the results seen with the Y2H assay, we analyzed the three mutants by the BiFC assay. The percentage of cells showing a vYFP signal after nitrogen starvation in the Atg17-VN strains with L105D, F317D, or I325D mutated was substantially decreased (Figures 4C and 4D) .
Next, we determined whether these mutations affected other known interactions of Atg17. Because Atg1 and Atg29 interact with Atg17 through Atg13 and Atg31, respectively, we tested the Atg17 point mutants for interaction with Atg13 and Atg31 by the Y2H assay. The Atg17 F317D mutant showed an essentially normal interaction with both Atg13 and Atg31, while Atg17 L105D and Atg17
I325D were particularly defective in interactions with
Atg13 and Atg31, respectively ( Figure 4E ).
Because the Atg17 F317D mutant was the only one that showed diminished interaction with Vam7 without substantially affecting its binding affinity to Atg13 and Atg31, we decided to focus our analysis on this mutant. First, the defective interaction of the mutant with Vam7 was further demonstrated by an in vitro affinity isolation assay. Although the GST-Vam7 SNARE domain chimera was able to affinity isolate Atg17-6xHis ( Figure 3G) , it was not able to efficiently pull down Atg17 F317D -6xHis ( Figures  4F and 4G) . We also examined whether the F317D mutation affects the efficiency of Atg17 movement to the PAS. During nitrogen starvation GFP-Atg17 F317D displayed significant colocalization with RFP-Ape1 (a PAS marker), at a frequency similar to the wild-type protein ( Figure S3D ).
As the next part of the analysis, we asked whether the Atg17 F317D mutant was competent for autophagy based on the Pho8D60 assay. Contrary to our expectations, the mutant Atg17 F317D did not affect the autophagy activity compared to the wild-type protein. The Atg17 L105D mutant showed almost a complete block of autophagy, while the Atg17 I325D mutant dis-
played an approximately 50% decrease in activity ( Figure 4H ). With either of the latter two mutants, however, we were not able to exclude the possibility that the defects in interaction with Atg13 or Atg31, rather than Vam7, led to the autophagy defects.
One possible explanation for the lack of an autophagy phenotype with the Atg17 F317D mutant is that the defect in the interaction with Vam7 is not severe enough to cause a detectable block in autophagy activity. We found that cells expressing ADAtg17 F317D and BD-Vam7 still grew quite well on plates lacking histidine (a less stringent selection condition), although they were not able to grow on plates without adenine (a harsher selection condition) ( Figure 4B ). In this case, the residual binding affinity may be adequate for autophagy to occur at a nearly wild-type level. A second possibility is that another protein might play a partially redundant role in recruiting Vam7 to the PAS, so that the autophagy activity defect from the Atg17 F317D mutant was complemented.
We tested the first possibility by isolating mutants that display more severe defects in the interaction between Vam7 than Atg17 F317D . Substitutions of glycine, histidine, lysine, or glutamine for Phe317, however, did not show a stronger block in binding ( Figure S3E ). Next, we made double mutants including Atg17 F317D,I325A , Atg17 F317D,I325G , and Atg17 F317G,I325G . Unfortunately, although these double mutants displayed a stronger defect in binding Vam7, they also had blocks in their interaction with either Atg13 or Atg31 (Figures S3F and S3G ; data not shown), preventing us from excluding the possibility that the F317D mutation caused only a weak phenotype.
Atg11 Recruits Vam7 to the PAS Independent of the Atg17-Atg31-Atg29 Complex Next, we tested the second possibility by looking at an Atg protein that may have a similar role in recruiting Vam7 as that proposed for Atg17. In this regard, Atg11 stands out for three reasons. First, Atg11 is predicted to have four major a-helical coiled-coil (CC) domains, similar to Atg17, which would allow it to engage in ''helix-helix'' interactions with Vam7. Second, like Atg17, Atg11 plays a role in formation and organization of the PAS [12, 35] . Third, the atg17D strain is able to generate a small number of autophagic bodies under starvation conditions, whereas an atg11D atg17D double mutant displays an essentially complete block in autophagy [35] . To assess this possibility, a Y2H assay was conducted in the MKO strain background to examine whether Atg11 could bind directly to Vam7. Cells with AD-Atg11 and BD-Vam7, but not control cells, grew on plates lacking histidine, suggesting a potential direct Atg11-Vam7 interaction ( Figure 5A ). However, the observation that they cannot grow on plates without adenine (data not shown) indicates that the Atg11-Vam7 interaction is weaker than that of Atg17-Vam7. Next, we tested Atg11 mutants that lack each of the four predicted coiled-coil domains to determine which region of Atg11 is involved in mediating the interaction. AD-Vam7 was still able to show binding affinity to AD-Atg11 D272-321 (DCC1) and AD-Atg11 D627-858 (DCC3), but not toward AD-Atg11 D536-576 (DCC2) or AD-Atg11
D859-1178
(DCC4), suggesting that the latter two a-helical domains of the protein are required for the interaction ( Figure 5A ). (E) MKO Y2H (YCY149) cells were co-transformed with the indicated plasmids. These cells were then grown as described in Figure 3E and grown in SMD-Ura medium to mid-log phase. The cells were then shifted to SD-N for 4 hr to induce autophagy, and the autophagy activity in these samples was analyzed by the Pho8D60 assay. The activity of atg17D (XLY134) cells with pCu-Atg17 (WT) after starvation was set to 100% and other values were normalized. The graph shows the average activity obtained from three independent experiments. Error bars represent the SD. **p < 0.01; ***p < 0.001. See also Figure S3 .
To further verify the interaction between Atg11 and Vam7, a BiFC assay was performed. In ATG11-VN VC-VAM7 cells, where Atg11-VN was expressed at its endogenous level, we were not able to detect a vYFP signal ( Figure 5B ). In contrast, the vYFP signal was observed in more than 90% of VN-ATG11 VC-VAM7 cells, in which Atg11 was tagged at its N terminus, and the VN-Atg11 chimera was overexpressed ( Figure 5B) . Although Atg11 can self-interact, the vYFP signal observed in these cells was not due to overexpression of VN-Atg11; cells expressing VN-ATG11 and VC alone, where both VN-Atg11 and the VC peptide were overexpressed, did not display a vYFP signal ( Figure 5B ).
We next examined whether this interaction occurs at the PAS. Indeed, more than 70% of VN-Atg11-VC-Vam7 vYFP dots colocalized with CFP-Atg8 under starvation conditions ( Figures 5C and 5D) . Previous studies have shown that Atg11 interacts with the Atg17-Atg31-Atg29 complex through Atg29 [12] . Therefore, we decided to examine whether Atg11-dependent recruitment of Vam7 to the PAS requires the ternary complex. We deleted either ATG17 or ATG29 in the VN-ATG11 VC-VAM7 strain and carried out a BiFC assay. Similar to the WT strain, significant colocalization of vYFP and CFP-Atg8 (70%) was still observed in both strains ( Figures  5C and 5D ). These data suggest that Atg11 can recruit Vam7 to the PAS independent of the Atg17-Atg31-Atg29 complex.
Impaired Recruitment of Vam7 to the PAS Results in a Defect in Autophagosome-Vacuole Fusion
We next tested whether the Atg17 F317D mutant would display a defect in autophagy activity in the atg11D background. In the atg11D atg17D background, compared to wild-type Atg17, the Atg17 F317D mutant showed an approximate 30% decrease in autophagy activity ( Figure 6A ), in contrast to the essentially wild-type activity seen in the atg17D background ( Figure 4H) . Moreover, the Atg17 I325D mutant, which had approximately 50% of the wild-type activity in the atg17D strain background, displayed almost a complete block of autophagy in the atg11D atg17D background.
To determine whether the autophagy defect, we observed with the Atg17 F317D mutant in the atg11D atg17D background was due to impaired autophagosome-vacuole fusion, we performed a protease protection assay [36] . In brief, the propeptide of the cytosolic precursor form of the vacuolar hydrolase aminopeptidase I (prApe1) is sensitive to cleavage by exogenous proteases added to lysed yeast spheroplasts; once enclosed in an autophagosome, however, the propeptide is protected from digestion ( Figure 6B ). In the vam7D cells, as a result of a block in autophagosome-vacuole fusion, approximately half of the prApe1 was protected from exogenously added proteinase K ( Figure 6C ). In contrast, the prApe1 was completely sensitive to proteinase K treatment in the atg11D atg17D cells, where autophagosome formation is defective. Compared to cells with wild-type Atg17, in the atg11D atg17D cells expressing the Atg17 F317D mutant, a small but consistent portion of the prApe1 pool was protected from proteinase K (Figures 6C and 6D) .
Next, to validate our protease protection assay data, we investigated the autophagosome structure of the Atg17 F317D mutant by correlative light and electron microscopy, combining fluorescence microscopy and tomography. GFP-Atg8 was utilized as a PAS/autophagosome marker to correlate the fluorescence with autophagosomal structures observed by EM. In both the atg17D vam7D cells expressing the Atg17
WT protein, and the atg11D atg17D cells expressing the Atg17 F317D mutant, we were able to observe circular double-membrane structures correlated with the GFP fluorescence signal in the sections examined by transmission electron microscopy (TEM) tomography ( Figure 6E ; Movies S1 and S2), suggesting that the autophagosomes in the Atg17 F317D mutant might be sealed.
However, with TEM tomography the sections are 0.3 mm, which are not of sufficient thickness to cover a complete autophagosome. Accordingly, we further investigated the autophagosomes in the Atg17 F317D mutant, using scanning transmission electron microscopy (STEM) tomography, which covers thicker sections (up to 2 mm) [37] . By this method, we observed fully closed autophagosomes in the Atg17 F317D mutant ( Figure 6E ; Movie S3).
To further support the observation that autophagosome formation in the Atg17 F317D mutant was not defective, we transformed either the empty vector or a plasmid expressing wild-type ATG17 or the ATG17 (F317D) mutant into atg11D atg17D vam7D cells, where the VAM7 deletion enhances the accumulation of completed autophagosomes. As expected, in those cells with the empty vector in which autophagosome formation was blocked, the prApe1 was completely sensitive to proteinase K treatment ( Figure S4 ). In contrast, in cells expressing the Atg17 F317D mutant, a substantial pool of the prApe1 was insensitive to proteinase K treatment, similar to that seen in cells with wild-type Atg17. Based on these results, we conclude that the autophagy defect seen with the Atg17 F317D mutant was due to defective autophagosome-vacoule fusion, but not autophagosome formation. See also Figure S4 and Movies S1, S2, and S3.
DISCUSSION
The Atg17-Atg31-Atg29 complex was identified as a scaffold indispensible for PAS organization and vesicle tethering at a very early stage of autophagy [12, 13] . In this study, we characterized a role of this complex in regulating autophagosome-vacuole fusion, a relatively late stage of the process. We found that the Atg17-Atg31-Atg29 complex recruits the vacuolar SNARE protein Vam7 to the PAS at an early stage of autophagy. In vitro and in vivo analyses indicate that Atg17 directly interacts with the SNARE core domain of Vam7. This interaction might block SNARE complex formation between Vam7 and other SNARE proteins, such as Vti1 and Vam3, inhibiting premature fusion of incomplete autophagosomes/phagophores with the vacuole. However, if this model is correct, it is not clear how Vam7 is released from Atg17 upon autophagosome maturation. Similar to many other Atg proteins, Atg17 will dissociate from the completed autophagosome and be recycled for the next round of autophagosome formation. A previous study has shown that the clearance of PtdIns3P by the phosphatase Ymr1 is required for disassembly of the Atg machinery from completed autophagosomes, which is a requisite for subsequent fusion with the vacuole [38] . We think it is possible that clearance of PtdIns3P promotes dissociation of Atg17 from autophagosomes, releasing Vam7 to mediate fusion between autophagosomes and the vacuole. In addition, we found that the PX domain of Vam7, which is able to bind PtdIns3P, is required for normal autophagy activity, even though it is not directly involved in mediating the Atg17-Vam7 interaction ( Figures 2D and S2C ). We think it is likely that the removal of PtdIns3P from the membrane normally releases the PX domain of Vam7, promoting the disassociation of the protein from Atg17. Atg11, which also functions as a scaffold protein in autophagy, interacts with Vam7 at the PAS independent of the Atg17-Atg31-Atg29 complex. Previous data suggest that Atg11 and Atg17 are partially redundant, with Atg11 functioning in selective types of autophagy, but also in PAS organization primarily under growing conditions [12, 35, 39] . Along these lines, we observed interaction between Atg11 and Vam7 under nutrient-rich conditions by the BiFC assay (data not shown). In contrast, Atg17 did not interact with Vam7 in this condition ( Figure 1A) . Also, a previous study has shown that Atg17 is not required for the cytoplasm-tovacuole targeting (Cvt) pathway that delivers resident hydrolases to the vacuole under growing conditions [8] . These lines of evidence suggest that Atg11 recruits Vam7 to Cvt vesicles as part of the Cvt pathway. This pool of Vam7 is enough for mediating the fusion of Cvt vesicles with the vacuole considering that the Cvt pathway essentially operates at a basal level relative to induced autophagy. Upon nitrogen starvation, autophagy is highly stimulated, and the Atg17-Atg31-Atg29 complex is now needed to recruit an adequate amount of Vam7 to the PAS.
Our analysis of the interaction between Atg17 and Vam7 reveals that certain hydrophobic residues in helix 1 and helix 4 Previous studies on the topic of autophagosome-vacuole/ lysosome fusion demonstrated a requirement for the general fusion machinery that operates at this organelle [14] [15] [16] [17] [18] [19] [20] [21] [22] [24] [25] [26] [27] . A major question, however, concerned the specific regulation of autophagosome-vacuole/lysosome fusion. Autophagy presents a unique situation in this regard compared to other vesicular transport pathways. For example, in the secretory pathway vesicles do not bud off from the originating organelle until they are essentially complete. Thus, fusion with the target/ acceptor organelle cannot occur prematurely. In contrast, the phagophore expands sequentially and thus must be prevented from fusing with the vacuole/lysosome prior to completion. In mammals, the functional counterpart of Atg17 is RB1CC1/ FIP200 [40] [41] [42] [43] . RB1CC1 is predicted to be largely helical. The similarity in secondary structure might imply a conserved role of RB1CC1 to recruit a SNARE protein(s) to the phagophore or autophagosomes. Recent studies in higher eukaryotes identified the autophagosomal SNARE protein STX17 that specifically mediates fusion of autophagosomes with lysosomes, together with SNAP29 and VAMP8 [26, 27] . It is not known whether RB1CC1 interacts with these SNARE proteins. During the preparation of our manuscript, it was reported that ATG14 interacts with STX17 and SNAP29 on mature autophagosomes to promote membrane tethering and the fusion of autophagosomes with lysosomes [44] . It is possible that RB1CC1 coordinates with ATG14 to recruit these SNAREs to autophagosomes in mammalian cells. Our study provides evidence that a similar specific mechanism is employed to regulate autophagosome-vacuole fusion in yeast. Overall, conserved molecular machinery might be employed to regulate autophagosome-vacuole/lysosome fusion.
EXPERIMENTAL PROCEDURES
Yeast Strains, Media, and Growth Conditions Yeast strains used in this study are listed in Table S1 . Under growing conditions, yeast cells were grown in YPD or SMD media [45] . To induce autophagy, cells were cultured in nitrogen starvation medium SD-N [45] .
Plasmids
For the Y2H assay, pGAD-Atg17 was constructed by ligation of the PCRamplified ATG17 open reading frame (ORF) fragment into the pGAD-C1 vector between the ClaI and SalI sites. Plasmids pGAD-Atg11(WT, D272-321, D536-576, D627-858, D859-1178), pGAD-Atg13, pGAD-Atg31, and pGBDU-Atg17 have been described previously [8, 10] . The truncation and point mutants of Atg17 were made by site-directed deletion or mutagenesis from either pGAD-Atg17 or pGBDU-Atg17. Plasmids pGBDU-Vam7, pGBDU-Vam7 (1-125), pGBDU-Vam7(119-254), and pGBDU-Vam7(241-317) were constructed by ligation of the corresponding PCR-amplified DNA fragments from the VAM7 ORF into the pGBDU-C1 vector between the EcoRI and BamHI sites. The deletion mutants of Vam7 were made by site-directed mutagenesis based on pGBDU-Vam7.
The ATG17 ORF fragment was ligated into the ClaI and SalI sites of pCu(416) [46] and pCu-GFP(416) vectors to construct pCu-Atg17(416) and pCu-GFPAtg17(416). Atg17 point mutants were then made by site-directed mutagenesis.
Fluorescence Microscopy
For fluorescence microscopy, images were captured on a DeltaVision microscope with a 1003 objective and a charge-coupled device (CCD) camera (CoolSnap HQ; Photometrics). Twelve Z-sections with 0.3-mm spacing between two neighboring sections were taken for each picture.
Other Methods
Western blot, the Pho8D60 assay, and the prApe1 protease protection assay were performed as described previously [33, 36, 47] . The detailed procedures for the BiFC assay, in vitro GST affinity isolation, and correlative light and electron microscopy analysis are described in the Supplemental Experimental Procedures. 
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